我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
194
15 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
进行中(未招募)
6
3.1%
Approved For Marketing
1
0.5%
已完成
87
44.9%
尚未招募
9
4.6%
招募中
20
10.3%
终止
3
1.6%
Unknown
64
33.0%
撤回
4
2.1%
暂无批准数据
- A nationwide Korean study of 5.7 million women found that longer reproductive lifespan is associated with progressively increased thyroid cancer risk. - Hormone replacement therapy use was linked to elevated thyroid cancer risk, with a stronger association observed among women receiving HRT for five years or more. - The study reported an incidence rate of approximately 2.4 per 1,000 people per year for thyroid cancer, with women disproportionately affected compared to men. - Researchers suggest that a woman's reproductive history, including menopause timing and hormone therapy use, could be considered in individual thyroid cancer risk assessment.